| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |